gut-vascular barrier controls systemic dissemination bacteria
healthy individuals intestinal microbiota access liver spleen peripheral tissues pathogenic bacteria can reach sites however can induce systemic immune response compartmentalization achieved unknown identify gut-vascular barrier gvb mice humans controls translocation antigens bloodstream prohibits entry microbiota salmonella typhimurium can penetrate gvb manner dependent pathogenicity island spi encoded type iii secretion system decreased beta-catenin-dependent signaling gut endothelial cells gvb modified celiac disease patients elevated serum transaminases indicates gvb dismantling may responsible liver damage patients understanding gvb may provide new insights regulation gut-liver axis
